Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.

Fractalkine (CX3C chemokine ligand 1, CX3CL1) is an essential chemokine, for regulating adhesion and chemotaxis through binding to CX3CR1, which plays a critical role in the crosstalk between glial cells and neurons by direct or indirect ways in the central nervous system (CNS). Fractalkine/CX3CR1 axis regulates microglial activation and function, neuronal survival and synaptic function by controlling the release of inflammatory cytokines and synaptic plasticity in the course of the neurological disease. The multiple functions of fractalkine/CX3CR1 make it exert neuroprotective or neurotoxic effects, which determines the pathogenesis. However, the role of fractalkine/CX3CR1 in the CNS remains controversial. Whether it can be used as a therapeutic target for neurological diseases needs to be further investigated. In this review, we summarize the studies highlighting fractalkine/CX3CR1-mediated effects and discuss the potential neurotoxic and neuroprotective actions of fractalkine/CX3CR1 in brain injury for providing useful insights into the potential applications of fractalkine/CX3CR1 in neurological diseases.

• Publication year

  2019

• Venue

  Brain Research Bulletin

• Publication date

  2019-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainresbull.2018.11.017PMID 30496784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis

  2019cited by this paper
• Electroacupuncture restores hippocampal synaptic plasticity via modulation of 5-HT receptors in a rat model of depression.

  2018cited by this paper
• Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes

  2017cited by this paper
• The role of the motor system in action naming in patients with neurodegenerative extrapyramidal syndromes.

  2017cited by this paper
• The hippocampal transcriptomic signature of stress resilience in mice with microglial fractalkine receptor (CX3CR1) deficiency.

  2017cited by this paper
• Burnout or depression: both individual and social issue.

  2017cited by this paper
• Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway

  2017cited by this paper
• Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease

  2016cited by this paper
• A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.

  2016cited by this paper
• Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?

  2016cited by this paper
• Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.

  2016cited by this paper
• Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress.

  2016cited by this paper
• Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.

  2016cited by this paper
• Fractalkine promotes chemotaxis of bone marrow‐derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization

  2015cited by this paper
• Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury

  2015cited by this paper
• Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease

  2015cited by this paper
• Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

  2015cited by this paper
• Depression as a microglial disease.

  2015cited by this paper
• Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation

  2015cited by this paper
• Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke

  2015cited by this paper
• Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration.

  2015cited by this paper
• Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity

  2015cited by this paper
• CX3CL1/CX3CR1-Mediated Microglia Activation Plays a Detrimental Role in Ischemic Mice Brain via p38MAPK/PKC Pathway

  2015cited by this paper
• Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ

  2015cited by this paper
• CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway

  2015cited by this paper
• Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity

  2015cited by this paper
• The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.

  2015cited by this paper
• Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway

  2014cited by this paper
• Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system

  2014cited by this paper
• CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis

  2014cited by this paper
• Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.

  2014cited by this paper
• CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity

  2014cited by this paper
• CX3CR1 RNAi inhibits hypoxia‐induced microglia activation via p38MAPK/PKC pathway

  2014cited by this paper
• Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling

  2014cited by this paper
• Causes of Death Among Persons Who Survive an Acute Ischemic Stroke

  2014cited by this paper
• Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.

  2014cited by this paper
• The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome

  2014cited by this paper
• Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.

  2014cited by this paper
• Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death

  2014cited by this paper
• Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke.

  2014cited by this paper
• CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke

  2014cited by this paper
• Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice.

  2013cited by this paper
• Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.

  2013cited by this paper
• Fractalkine (CX3CL1) enhances hippocampal N-methyl-d-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A2AR) activity

  2013cited by this paper
• Factors regulating microglia activation

  2013cited by this paper
• Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β

  2013cited by this paper
• CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice

  2013cited by this paper
• Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency.

  2013cited by this paper
• Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy

  2013cited by this paper
• Pathogenesis of Parkinson's disease

  2013cited by this paper
• CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes.

  2013cited by this paper
• Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function

  2013cited by this paper
• Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain

  2013cited by this paper
• Current status of chemokines in the adult CNS.

  2013cited by this paper
• Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer's Disease

  2013cited by this paper
• Stress-Induced Recruitment of Bone Marrow-Derived Monocytes to the Brain Promotes Anxiety-Like Behavior

  2013cited by this paper
• Altered expression of CX3CL1 in patients with epilepsy and in a rat model.

  2012cited by this paper
• Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.

  2012cited by this paper
• Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke

  2012cited by this paper
• The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity

  2012cited by this paper
• CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.

  2012cited by this paper
• The Soluble Isoform of CX3CL1 Is Necessary for Neuroprotection in a Mouse Model of Parkinson's Disease

  2012cited by this paper
• Fractalkine Gene Receptor Polymorphism in Patients With Multiple Sclerosis

  2012cited by this paper
• Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice.

  2012cited by this paper
• Amyloid &bgr; Enhances Migration of Endothelial Progenitor Cells by Upregulating CX3CR1 in Response to Fractalkine, Which May Be Associated With Development of Choroidal Neovascularization

  2011cited by this paper
• CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

  2011cited by this paper
• CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity

  2011cited by this paper
• Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What

  2011cited by this paper
• New evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease.

  2011cited by this paper
• CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents

  2011cited by this paper
• Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

  2011cited by this paper
• Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression.

  2011cited by this paper
• Amyloid-dependent and amyloid-independent stages of Alzheimer disease.

  2011cited by this paper
• A pathophysiological framework of hippocampal dysfunction in ageing and disease

  2011cited by this paper
• CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.

  2010cited by this paper
• Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide

  2010cited by this paper
• CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

  2010cited by this paper
• Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

  2010cited by this paper
• CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

  2010cited by this paper
• Regulation of tau pathology by the microglial fractalkine receptor.

  2010cited by this paper
• Multi‐targeted neuroprotection by the HSV‐2 gene ICP10PK includes robust bystander activity through PI3‐K/Akt and/or MEK/ERK‐dependent neuronal release of vascular endothelial growth factor and fractalkine

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• Adenosine A1 Receptors and Microglial Cells Mediate CX3CL1-Induced Protection of Hippocampal Neurons Against Glu-Induced Death

  2010cited by this paper
• Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus.

  2009cited by this paper
• Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease

  2009cited by this paper
• LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R).

  2009cited by this paper
• Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats.

  2009cited by this paper
• Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease

  2009cited by this paper
• MFG-E8 Regulates Microglial Phagocytosis of Apoptotic Neurons

  2008cited by this paper
• Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.

  2008cited by this paper
• Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons1

  2008cited by this paper
• Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease.

  2008cited by this paper
• Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse

  2008cited by this paper
• Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

  2008cited by this paper
• Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.

  2007cited by this paper
• Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

  2007cited by this paper
• Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain

  2007cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Chemokines: a new class of neuromodulator?

  2007cited by this paper

• Microglial CX3CR1 deficiency regulates the selective vulnerability of cone photoreceptors via STAT3/CCL–ACKR1 signaling in the mouse retina

  2026cites this paper
• Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease.

  2026cites this paper
• Potentiated fractalkine signaling axis affects neuroinflammation in 1,2-dichloroethane- intoxicated mice via divergent modulating ways on microglial hyperactivation.

  2025cites this paper
• Distinct neuroprotective and anti-inflammatory effects of Kampo formulas ninjinyoeito and juzentaihoto in depression-like SAMP8 mice

  2025cites this paper
• Sex-specific dysregulation of the CX3CL1/CX3CR1 Axis following cocaine exposure: Translational evidence for a potential biomarker of abstinence

  2025cites this paper
• Mechanisms and routes of G-protein coupled receptor-mediated Tau degradation in Alzheimer's disease.

  2025cites this paper
• Fractalkine and Neuroinflammation in Autism Spectrum Disorder: A Novel Perspective

  2025cites this paper
• Central nervous system and systemic inflammatory networks associated with acute neurological outcomes in COVID-19

  2025cites this paper
• Role of chemokines in depression: Highlights on CX3CL1/CX3CR1 signaling

  2025influential citation
• Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration

  2025cites this paper
• "Maladaptive Stress-Coping Behavior in CX3CR1-Deficient Mice: Impact of Adolescent Stress and Alcohol Exposure on Neuroimmune Responses and Inflammation".

  2025cites this paper
• Age- and cytokine-dependent modulation of GABAergic transmission within the basolateral amygdala of male Sprague Dawley rats.

  2025cites this paper
• The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications

  2025cites this paper
• CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases

  2025cites this paper
• Glial interactions in the formation and plasticity of the corpus callosum

  2025cites this paper
• CX3CL1/CX3CR1 Signaling Mediated Neuroglia Activation Is Implicated in the Retinal Degeneration: A Potential Therapeutic Target to Prevent Photoreceptor Death

  2024cites this paper
• Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

  2024cites this paper
• Unveiling the immunomodulatory role of soluble chicken fractalkine: insights from functional characterization and pathway activation analyses.

  2024cites this paper
• Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy

  2024cites this paper
• Dynamics of Cellular Regulation of Fractalkine/CX3CL1 and Its Receptor CX3CR1 in the Rat Trigeminal Subnucleus Caudalis after Unilateral Infraorbital Nerve Lesion—Extended Cellular Signaling of the CX3CL1/CX3CR1 Axis in the Development of Trigeminal Neuropathic Pain

  2024cites this paper
• Impacts of SARS-CoV-2 on brain renin angiotensin system related signaling and its subsequent complications on brain: a theoretical perspective.

  2024cites this paper
• CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis

  2024cites this paper
• Cell type–specific gene therapy confers protection against motor neuron disease caused by a TFG variant

  2024cites this paper
• Restoration of injured motoneurons reduces microglial proliferation in the adult rat facial nucleus.

  2024cites this paper
• Levels of preoperative cerebrospinal fluid pro‐inflammatory mediators and chronic pain after total knee arthroplasty surgery

  2023cites this paper
• Conserved cell-type specific signature of resilience to Alzheimer’s disease nominates role for excitatory intratelencephalic cortical neurons

  2023cites this paper
• NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE

  2023cites this paper
• Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease

  2023influential citation
• Chronic hyperpalatable diet induces impairment of hippocampal-dependent memories and alters glutamatergic and fractalkine axis signaling

  2023cites this paper
• Parkinson's disease is positively associated with periodontal inflammation.

  2023cites this paper
• Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives

  2023cites this paper
• Microglial cell response to experimental periodontal disease

  2023cites this paper
• CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer’s Disease

  2023cites this paper
• Fibromyalgia – etiology, diagnosis and treatment including perioperative management in patients with fibromyalgia

  2023cites this paper
• Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke

  2022cites this paper
• Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy

  2022cites this paper
• Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease

  2022cites this paper
• Neuron‐glia crosstalk in neuronal remodeling and degeneration: Neuronal signals inducing glial cell phagocytic transformation in Drosophila

  2022cites this paper
• The Molecular Basis of Resilience: A Narrative Review

  2022cites this paper
• Laminar shear stress alleviates monocyte adhesion and atherosclerosis development via miR-29b-3p/CX3CL1 axis regulation

  2022cites this paper
• Adipose tissue, systematic inflammation, and neurodegenerative diseases

  2022cites this paper
• Structure and function of ligand CX3CL1 and its receptor CX3CR1 in cancer.

  2022cites this paper
• Events Occurring in the Axotomized Facial Nucleus

  2022cites this paper
• CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway

  2022cites this paper
• High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia

  2022cites this paper
• Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system

  2022cites this paper
• Microglial diversity along the hippocampal longitudinal axis impacts synaptic plasticity in adult male mice under homeostatic conditions

  2022cites this paper
• Correlation between LOX-1 and CX3CR1 and Vascular Endothelial Function, Fibrinolytic Activity, and Recurrence after Thrombolysis in Patients with Cerebral Infarction

  2022cites this paper
• Blocking PSD-93-CX3CL1 Interaction Promotes Phenotypic Polarization Transformation of Microglia During Acute Ischemic Stroke Injury

  2021cites this paper
• Blocking PSD-93-CX3CL1 Interaction Promotes the Phenotypic Transformation of Microglia During Acute Ischemic Stroke

  2021cites this paper
• TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man

  2021cites this paper
• Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells

  2021cites this paper
• Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?

  2021cites this paper
• Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats

  2021cites this paper
• The progress of chemokines and chemokine receptors in autism spectrum disorders.

  2021cites this paper
• Upregulation of Neuronal Cylindromatosis Expression is Essential for Electroacupuncture-Mediated Alleviation of Neuroinflammatory Injury by Regulating Microglial Polarization in Rats Subjected to Focal Cerebral Ischemia/Reperfusion

  2021cites this paper
• Axonal chemokine-like Orion induces astrocyte infiltration and engulfment during mushroom body neuronal remodeling

  2021cites this paper
• Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity

  2021cites this paper
• Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection

  2021cites this paper
• Microglia as the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia

  2021cites this paper
• Neurons, Glia, Extracellular Matrix and Neurovascular Unit: A Systems Biology Approach to the Complexity of Synaptic Plasticity in Health and Disease

  2020influential citation
• Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications.

  2020cites this paper
• Disease Progression-Dependent Expression of CD200R1 and CX3CR1 in Mouse Models of Parkinson’s Disease

  2020cites this paper
• TNF-α Pretreatment Improves the Survival and Function of Transplanted Human Neural Progenitor Cells Following Hypoxic-Ischemic Brain Injury

  2020cites this paper
• Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection

  2020cites this paper
• Axon-secreted chemokine-like Orion is a signal for astrocyte infiltration during neuronal remodeling

  2020cites this paper
• Synaptic Pruning in Schizophrenia: Does Minocycline Modulate Psychosocial Brain Development?

  2020cites this paper
• Upregulation of Chemokines in the Paraventricular Nucleus of the Hypothalamus in Rats with Stress-Induced Hypertension

  2020cites this paper
• The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders

  2020cites this paper
• The delicate balance between neurotoxicity and neuroprotection in the context of HIV‐1 infection

  2020cites this paper
• Elevated inflammatory proteins in cerebrospinal fluid from patients with painful knee osteoarthritis are associated with reduced symptom severity.

  2020cites this paper
• Unique, long-term effects of nicotine on adolescent brain.

  2020cites this paper
• CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage

  2020cites this paper
• Regulation of CNS precursor function by neuronal chemokines.

  2020cites this paper
• Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington’s Disease

  2020cites this paper
• Time course of blood and brain cytokine/chemokine levels following adolescent alcohol exposure and withdrawal in rats.

  2019cites this paper
• What Do Microglia Really Do in Healthy Adult Brain?

  2019influential citation
• CX3CR1-CX3CL1-dependent cell-to-cell Japanese encephalitis virus transmission by human microglial cells

  2019cites this paper
• Spora: A Journal of Biomathematics Spora: A Journal of Biomathematics

  year unknowncites this paper
• Distinct neuroprotective and anti-in fl ammatory effects of Kampo formulas ninjinyoeito and juzentaihoto in depression-like SAMP8 mice

  year unknowncites this paper